Analytical Data
-
Gene name
CTRB2
- Application
-
Species
Human
-
Source
E. coli
-
Tag
N- His & GST
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q6GPI1
-
Expression Region
Ile34~Asn263
-
Molecular Weight
54&50kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CTRB2 (chymotrypsinogen B2) is a serine protease that plays a significant role in various physiological processes, including digestion and immune response. It is primarily produced in the pancreas and has been implicated in several pathological conditions, including pancreatitis and cancer. Recent research has highlighted its potential as a biomarker for pancreatic diseases, prompting interest in the characterization of CTRB2 and its recombinant forms. Recombinant protein technology enables the production of CTRB2 in host systems, allowing for the study of its structure, function, and interactions with substrates and inhibitors. Understanding CTRB2 at the molecular level can reveal insights into its regulatory mechanisms and therapeutic potential. Moreover, recombinant CTRB2 can serve as a valuable tool for developing diagnostic assays and therapeutic agents. The interest in CTRB2 recombinant protein research is driven by the need to explore its therapeutic applications and understand its biological significance, ultimately contributing to advancements in clinical diagnostics and treatment strategies for pancreatic disorders.
